過程分析設備：市場佔有率分析、產業趨勢與統計、成長預測（2024-2029）

Process Analytical Instrumentation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

出版日期: 2024年02月15日 | 出版商:

Mordor Intelligence | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

過程分析儀市場規模預計到2024年為 56.7 億美元，預計到2029年將達到 81.9 億美元，在預測期內（2024-2029年）成長 7.61%。年複合成長率為

主要亮點

程式工程中使用最廣泛的分析是製程氣體層析法。它是最常用的氣體分析方法，因為它可以同時分析多種成分。氣相層析儀有大量的停機時間，需要仔細監控。氣相層析由一系列精選的製程模組化爐組成，可使用單獨的模組進行維修和更換。此外，這還可以減少設備停機時間並提高流程生產力。過程氣相層析是碳氫化合物和其他複雜氣體分析中使用最廣泛的分析儀器，但客戶發現製程氣相層析很困難。
製造業自動化的成長推動了所研究市場的發展。由於工業4.0世界的影響，製造業正走向自動化。過程分析設備非常適合這一不斷發展的趨勢。例如，透過將標準與基本現場匯流排和電子設備說明語言等數位通訊技術整合，可以輕鬆存取設備收集的資訊，增強流程並實現持續的準確性。
近年來，所研究市場的成長是由程式工程中設備使用的增加、全球對藥品的高投資、藥品安全方面的嚴格監管、對食品質量的日益重視以及原油的開發等因素推動的。頁岩氣生產以及質譜儀的技術進步。光譜儀在環境、石化、食品安全、冶金、地球化學和臨床毒理學研究中得到應用。這些產品主要用於中國、印度和拉丁美洲市場，以符合日益嚴格的國際環境和消費者安全法規。
此外，市場的未來也受到以下因素的影響：全球對藥品的大量投資，嚴格的藥品安全法規，原油和頁岩氣產量的擴大以及對食品品質的日益關注以及質譜儀的技術進步。
然而，分析儀器的軟體許可必須被視為所研究市場的主要挑戰之一，因為許可因公司而異。例如，有些可能允許使用其他電腦上的軟體來處理資料。有些要求為此目的購買第二張許可證。因此，此類問題可能會對預測期內所研究市場的成長產生負面影響。
COVID-19 爆發期間，全球經濟面臨壓力。經過多年的強勁成長，全球貿易放緩，主要是由於歐洲和美國問題的累積。未來新興國家也可能出現類似的問題。然而，這些短期走勢應該揭示全球貿易體系的長期結構性變化，預計這些變化將有利於所研究的市場。

過程分析技術市場趨勢

製藥和生物技術經歷顯著成長

該部門包括從事藥品和藥品製造的公司。它還包括提供用於治療和診斷的醫療設備的公司。
生物製藥製造業依靠分析測試來提高生產力、製程最佳化和監控、生技藥品和生物學名藥表徵以及即時產品品管。所有這些對於在生物製造中創建更簡化的流程非常重要，降低成本、更一致的產品品質以及整體上更有效率的製造。
製藥業一直在尋求提高產品品質的方法。隨著時間的推移，隨著設備變得越來越準確，業界也變得更加重視效率。因此，增加對藥物研發的投資將為所研究市場的成長創造良好的前景。例如，根據 EvaluatePharma 的資料，預測期內全球藥物研發支出預計將達到 2,540 億美元。
此外，層析法和光譜等重要的分析工具獲得新的地位。 GC 用於後製，因為層析法（GC）設備可以分析小而輕的化合物。換句話說，GC是品管中的一個標準流程。然而，氣相層析在製藥業的主要應用是揮發性雜質的鑑定。
光譜學有多種技術，每種技術在不同的生產階段都表現出色。雖然近紅外線（NIR）和傅立葉轉換紅外線（FTIR）吸收光譜等一些方法已廣泛接受，但兆赫光譜等新技術的廣泛採用也可能有利於藥品生產。最近，光譜學也開始關注藥物的結構組成和分佈。它還在品管方面有其他應用，有助於檢驗製造過程和最終產品是否符合嚴格的合規性和監管控制。這些趨勢將有利於所研究市場未來的成長。

北美佔有很大的市場佔有率

北美製程分析技術（PAT）和設備供應商在過去幾年中不斷提高其技術的易用性、準確性、可靠性和有效性。該領域的公司引進了技術開發和其他創新，以更佳支援實驗室和 QA/QC業務。
石油和天然氣、金屬和採礦以及製藥等行業的傳統生產方法包括包括製造最終產品和實驗室分析以檢驗最終成品品質的過程。然而，這些傳統方法有幾個缺點，包括反覆出現的製造困難、持續的製程最佳化以及批次失敗的可能性。因此，為了克服這些缺陷，FDA（美國食品藥物管理局）引進了一種稱為PAT的新技術來改變操作模式。
美國FDA 發布了實施 PAT 的法規結構概述。透過此框架，FDA 尋求鼓勵製藥業加強其生產流程。例如，2021年1月，ENVEA推出了一款新型可攜式多氣體監測儀。它目的是滿足監管和定期排放監測的要求，同時節省使用者全天現場時間。 MIR 9000P 符合全球法規和標準，包括美國EPA。它保證了 8 個參數（NOx、SO2、CO、CO2、CH4、N2O、O2 和殘餘 H2O）的出色精度和寬測量範圍。分析儀採用具有氣體過濾相關性（NDIR-GFC）（SRM）的非色散紅外線技術，同時使用內建順順磁性感測器測量 O2。
由於美國和加拿大這兩個國家在研發方面投入大量，並且在生命科學、石油和天然氣、材料科學、製藥和生物製藥行業中佔有顯著份額，該地區擁有過程分析儀器市場的主要份額。根據Pharmaceutical Commerce表示，美國的藥品市場成長。到2023年，預計美國人將在藥品上花費635至6550億美元；與2019年相比，這顯示2020年支出將穩定成長 29.6-33.7%。
新藥核准的增加將大幅促進藥品解決方案的成長，並加強對藥品製造過程中分析溶液的化學成分或物理性質的製程分析設備的要求。例如，FDA 藥物評估與研究中心（CDER）於2022年核准了37 種新藥和生物製藥。此外，2022年核准的37 種新藥中有20 種（54%）被 CDER 認定為First-in-Class。

流程分析技術產業概況

過程分析設備市場由幾家主要公司細分。兩家公司繼續投資於策略合作夥伴關係和產品開發，以獲得市場佔有率。該市場的主要參與者包括 ABB Ltd、Siemens AG、Bruker Corporation、Emerson Electric Co.和 Endress &Hauser。市場的最新發展包括：

2023年 4月 - 印度科學技術部發起舉措，該部將為該部支持下建立的儀器設施（AIF）的維護和劣化提供財政支持。政府的設備升級預防性維修和維護支援（SUPREME）計劃擴大了對維護、維修、劣化或購買額外配件的財政支持，以提高現有分析儀設備的功能能力。
2022年 6月 - Endress+Hauser AG 推出 LiquilineSystem CA80TN，可提供準確且定期合規的總氮線上測量。 LiquilineSystem CA80TN 比色分析儀提供即時氮值，協助廢水處理廠管理者控制流程。 CA80TN 分析儀的鈦反應器及其硬塗層濾光片可提供卓越的長期性能。

其他福利

Excel 格式的市場預測（ME）表
3 個月分析師支持

Key Highlights

The most vastly used analysis for process engineering is process gas chromatography. It is the most utilized method for gas analysis since it permits multiple components to be analyzed alongside. Gas chromatographs have plenty of downtime and need a lot of supervision. The gas chromatograph consists of a process modular oven choice that another module may fix and replace. Furthermore, this may decrease equipment downtime & improve process productivity. Customers find process gas chromatographs difficult, although they are the most broadly used analyzer for hydrocarbon & other complicated gas analyses.
The growth of automation in the manufacturing sector has driven the development of the market studied. With the worldwide impact of Industry 4.0, the manufacturing industry is going toward automation. Process analytical instruments are a good fit with this evolving trend. For instance, integrating digital communications technologies & standards like foundation fieldbus & electronic device description language has constructed the information collected by the instruments readily accessible to enhance the process and deliver persistent accuracy.
In current years, the increase in the market studied has been driven by factors like the growing use of the equipment in process engineering, high investments in pharmaceuticals worldwide, strict regulations on drug safety, growing emphasis on the quality of food products, development of crude and shale gas production, and technological advancements in mass spectrometers. Spectrometers are discovering applications in environmental, petrochemical, food safety, metallurgical, geochemical, & clinical toxicology research. These products are primarily used in markets like China, India, and Latin America to help comply with growing stringent international environmental & consumer safety regulations.
Furthemore, the future of the market is anticipated to have a greater influence of factors such as a high investments in pharmaceuticals across the globe, stringent safety regulations medicines, the expansion of crude oil and shale gas production, increasing attention to food quality and technological advances in mass spectrometers.
However, analytical instrumentation's software licensing should be considered among the major challenging factor to the studied market, as different companies have different licenses. For instance, some allow the use of software on other computers for data processing; while others require the purchase of a second license for this purpose. Hence, such issues may negatively impact the growth of the market studied market during the forecast period.
During COVID-19 global economy was under stress. After many years of strong growth, global trade slowed, mainly due to the accumulation of problems in Europe and the United States. Similar issues might arise in emerging economies in the future. However, these short-term dynamics should clarify the longer-term structural changes in the global trading system which is anticipated to work in favor of the studied market.

Process Analytical Technology Market Trends

Pharmaceutical and Biotechnology is Observing a Significant Growth

This segment contains firms engaged in manufacturing medicinal & pharmaceutical products. It also contains companies delivering healthcare devices utilized for treatment or diagnosis.
The biopharmaceutical manufacturing industry relies on analytical testing to help improve productivity, optimize and monitor processes, characterize biologics and biosimilars, and provide real-time product quality control. All these are essential in creating a more streamlined process within biomanufacturing, resulting in lower costs, more consistent product quality, and more efficient manufacturing across the board.
The pharmaceutical industry has always searched for ways to improve product quality. Over time, as instrument accuracy and precision improved, the industry began focusing more on efficiency. Hence, the growing investment in pharmaceutical research and development will create a favorable outlook for the growth of the studied market. For instance, according to EvaluatePharma, global spending on pharmaceutical research and development is anticipated to reach USD 254 billion during the forecast period.
Furthermore, crucial analytical tools like chromatography and spectroscopy are gaining new ground. Since chromatography (GC) machines can analyze tiny and light compounds, GC is used in post-production. In other words, GC is a standard process during quality control. However, identifying volatile impurities is the primary use of GC within the pharmaceutical industry.
There are several optical spectroscopy techniques, and each excels at various manufacturing stages. While some methods enjoy wide acceptance, such as near-infrared (NIR) and Fourier transform infrared (FTIR) absorption spectroscopy, broader adoption of newer techniques, such as terahertz Raman spectroscopy, can also benefit pharmaceutical production. More recently, spectroscopy has also begun to focus on the structural composition and distribution of pharmaceutical products. It has additional applications in quality control, which help validate that the manufacturing process and end products meet strict compliance and regulatory controls. Such trends will favor the growth of the studied market in future.

North America to Hold a Significant Market Share

Process analytical technology (PAT) and instrument vendors in North America have continually advanced their technology's usability, accuracy, reliability, and efficacy in the past few years. Companies in this sector introduced technological developments and other innovations to better support lab and QA/QC operations.
The traditional ways of production in the industries, such as oil and gas, metal and mining, and pharmaceuticals, involved processes that included manufacturing of the finished products and laboratory analysis for verifying the quality of the final finished products. However, these traditional methods have some drawbacks as recurring manufacturing difficulties, constant process optimization, and the probability of failed batches. Thus, to overcome these glitches, the new technology known as PAT was introduced by FDA (Food and Drug Administration) to change the mode of operation.
The US FDA has outlined a regulatory framework for PAT implementation. With this framework, the FDA tries to motivate the pharmaceutical industry to enhance the production process. For instance, in January 2021, the new portable multi-gas monitor was launched by ENVEA, intending to meet the demands of regulatory and routine stack emission monitoring while saving users'' time throughout their on-site day. The MIR 9000P complies with global regulations and standards, including US EPA's. For eight parameters, it ensures great accuracy and wide measuring ranges (NOx, SO2, CO, CO2, CH4, N2O, O2, and residual H2O). The analyzer uses a built-in paramagnetic sensor to measure O2 while using the non-dispersive infrared technique with gas filter correlation (NDIR-GFC) (SRM).
Owing to the existence of the United States and Canada, which are the countries that spend a substantial amount on research and development and hold a prominent share in life sciences, oil and gas, materials sciences, pharma, and biopharma industries, the region holds a major share of the process analytical instrumentation market. According to Pharmaceutical Commerce, the pharmaceutical market is on the rise in the United States. By 2023, it is expected that Americans will spend USD 635 to USD 655 billion on pharmaceuticals; compared to 2019, this indicated a solid 29.6-33.7% rise in spending in 2020.
The increase in the approval of new drugs would significantly drive the rise of pharmaceutical solutions, which would enhance the requirement of process analytical instruments to analyze the chemical composition or physical properties of the solution during drug making. For instance, the FDA's Center for Drug Evaluation and Research (CDER) approved 37 new drugs and biological products in 2022. Furthermore, 20 of the 37 novel drugs approved in 2022 (54%) were identified by CDER as first-in-class.

Process Analytical Technology Industry Overview

The process analytical instrumentation market is fragmented, with several major companies. The companies continuously invest in strategic partnerships and product developments to gain market share. Some major players in the market are ABB Ltd, Siemens AG, Bruker Corporation, Emerson Electric Co., and Endress & Hauser. Some of the recent developments in the market are:

April 2023 - India's Science and Technology Minister launched an initiative under which the ministry will provide financial support for the maintenance and degradation of analytical instrumentation facilities (AIFs) created under the ministry's support. The Support for Up-gradation Preventive Repair and Maintenance of Equipment (SUPREME) program by the government extends financial support for maintenance, repair, degradation, or acquiring additional attachments to increase the functional capabilities of existing analytical instrumentation facilities.
June 2022 - Endress + Hauser AG launched the LiquilineSystem CA80TN, which provides a precise and regular-compliant online measurement of total nitrogen. The LiquilineSystem CA80TN colorimetric analyzer could deliver real-time nitrogen values, helping wastewater treatment plant managers control their processes. The titanium reactor of the CA80TN analyzer and its hard-coated optical filters could offer superior long-term performance.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

1 INTRODUCTION

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

4.1 Market Overview
4.2 Industry Value Chain Analysis
4.3 Industry Attractiveness - Porter's Five Forces Analysis
- 4.3.1 Bargaining Power of Suppliers
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of New Entrants
- 4.3.4 Threat of Substitutes
- 4.3.5 Degree of Competition
4.4 Impact of COVID-19 on the Market

5 MARKET DYNAMICS

5.1 Market Drivers
- 5.1.1 Introduction of High-efficient Motors
- 5.1.2 Increasing Adoption of Power Management and Predictive Maintenance Solutions
5.2 Market Challenges
- 5.2.1 Dynamic Global Economy

6 MARKET SEGMENTATION

6.1 By Type
- 6.1.1 Gas Chromatographs
- 6.1.2 Gas Analyzers
- 6.1.3 Liquid Analyzers
- 6.1.4 Spectrometers
6.2 By End-user Industry
- 6.2.1 Oil and Gas
- 6.2.2 Chemicals & Petrochemicals
- 6.2.3 Pharmaceutical & Biotechnology
- 6.2.4 Metal & Mining
- 6.2.5 Water & Wastewater
- 6.2.6 Other End-user Industries
6.3 By Geography
- 6.3.1 North America
- 6.3.2 Europe
- 6.3.3 Asia-Pacific
- 6.3.4 Rest of the World

7 COMPETITIVE LANDSCAPE

7.1 Company Profiles
- 7.1.1 ABB Ltd.
- 7.1.2 Siemens AG
- 7.1.3 Bruker Corporation
- 7.1.4 Emerson Electric Co.
- 7.1.5 Endress & Hauser AG
- 7.1.6 Extrel CMS LLC
- 7.1.7 Focused Photonics Inc.
- 7.1.8 Hach Company
- 7.1.9 Horiba Ltd
- 7.1.10 Mettler Toledo
- 7.1.11 MKS Instruments Inc.
- 7.1.12 Neo Monitors AS
- 7.1.13 Schneider Electric SE
- 7.1.14 ServomexGroup Limited
- 7.1.15 SICK AG